You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

149 Results
Drug
Other Name(s): Votrient®
Dec 2025
Drug
Other Name(s): Arimidex®
Updated
Dec 2025
Drug
Other Name(s): Afinitor®
Dec 2025
Drug
Other Name(s): Xgeva®; Wyost™; Osenvelt™
Dec 2025
Drug
Other Name(s): Yervoy®
Dec 2025
Drug
Other Name(s): Iclusig®
Dec 2025
Drug
Other Name(s): Opdivo®
Dec 2025
Regimen
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
May 2019
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Dec 2025
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Dec 2025
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Dec 2025
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019

Pages